Effect of Roxadustat versus erythropoietin (EPO) for treating anemia in patients with diabetic kidney disease: a retrospective cohort study.
Annals of translational medicine（2022）
摘要
In DKD patients, Roxadustat improves renal anemia. Effect of Roxadustat is similar to that of EPO.
更多查看译文
关键词
Roxadustat,diabetic kidney disease (DKD),renal anemia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要